Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Personalized Gait Retraining to Support Knee Health in Older Adults (BiofeedbackRCT)

15 november 2026 bijgewerkt door: Lauri Stenroth, University of Eastern Finland

A Real-time Biofeedback Intervention for Improving Tibiofemoral Cartilage Quality in Older Adults

Participants are randomized into two groups: gait retraining and habitual walking. In the gait retraining group, an intervention consisting of 10 training sessions on a treadmill aims to reduce medial tibiofemoral joint loading during walking. Real-time visual biofeedback on a knee joint loading metric is provided during some of the training sessions to facilitate learning. The habitual walking group participates in an equal number of training sessions where they perform their habitual walking and do not try to change their walking technique. Changes in knee joint cartilage properties are assessed at 5 months.

Studie Overzicht

Toestand

Nog niet aan het werven

Conditie

Gedetailleerde beschrijving

In this randomized controlled intervention study, participants are randomized into two groups: gait retraining and habitual walking. At baseline and five months later, participants' gait mechanics and knee joint cartilage structure and quality are assessed, and blood and urine samples and questionnaire data are collected. In addition, knee joint radiographic status is assessed at baseline. Physical activity is monitored using a thigh-worn accelerometer throughout the study.

The intervention consisting of 10 training sessions on a treadmill aims to reduce medial tibiofemoral joint loading during walking. During the first session, participants try different kinematics-based gait modifications to personalize the intervention. The modifications that reduce estimated medial tibiofemoral knee joint loading the most are selected and utilized during the following sessions. The gait retraining aims at establishing a gait pattern for each individual that reduces medial tibiofemoral joint loading while also being such that the person can utilize it in their daily living. To support learning and fine-tuning the gait pattern, real-time feedback on knee joint moments is provided during part of the training sessions. The habitual walking group participates in an equal number of training sessions where they perform their habitual walking and do not try to change their walking technique. Eight of the training sessions are conducted within four weeks, while the two remaining sessions (so-called boosters) are conducted during the following four months with the aim of supporting maintenance of the learned gait pattern.

Pre-planned additional follow-ups are planned for 12 and 24 months from baseline. Knee MRI would be conducted at these follow-up points, with implementation depending on funding.

Studietype

Ingrijpend

Inschrijving (Geschat)

70

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studiecontact

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

65 jaar tot 74 jaar (Oudere volwassene)

Accepteert gezonde vrijwilligers

Ja

Geslachten die in aanmerking komen voor studie

Allemaal

Beschrijving

Inclusion Criteria:

  • Age above 65 or below 75 years (in full years)
  • Access to a smartphone or tablet with an Android or iOS operating system

Exclusion Criteria:

  • Unable to walk for 30 minutes without stopping and without an assistive device
  • Body mass index <18 or >30 kg/m2
  • Pain during walking
  • Diagnosed with knee osteoarthritis
  • Moderate (KL Grade 3) or severe (KL Grade 4) radiographical tibiofemoral osteoarthritis based on Kellgren-Lawrence (KL) Classification of Osteoarthritis
  • Diagnosed with neurological disease
  • Surgery of the knee joint
  • Surgery or injury to the lower limbs causing pain or affecting mobility
  • Current musculoskeletal injury causing pain or affecting mobility
  • Contraindication for magnetic resonance imaging
  • Contraindication for walking-based exercise training (e.g., cardiovascular symptoms that increase with exercise or recommendation from a medical professional to avoid moderate exercise)
  • Any other condition that, in the opinion of the investigator, makes a potential participant unfit for participation or conditions that put a potential participant at risk by participation

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Fundamentele wetenschap
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Enkel

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Experimenteel: Gait retraining

The arm receives personalized gait retraining via treadmill walking and real-time feedback.

Personalized gait retraining using small kinematic alterations guided by real-time feedback of knee joint loading. The training is perfomed on a treadmill.

Ander: Habitual walking

The arm receives equal amount of treadmill walking without feedback or instruction to alter the gait.

Participants receive equal amount of treadmill walking as the ones receiving gait retraining intervention. This intervention serves as the comparator for the gait retraining intervention.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Medial tibiofemoral T1ρ relaxation time
Tijdsspanne: Baseline and 5 months

T1ρ relaxation time map of tibiofemoral cartilage from the medial compartment of the knee joint assessed using 3T MRI

Baseline and 5 months

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Medial tibiofemoral T2 relaxation time
Tijdsspanne: Baseline and 5 months

T2 relaxation time map of tibiofemoral cartilage from the medial compartment of the knee joint assessed using 3T MRI

Baseline and 5 months
Lateral tibiofemoral T1ρ relaxation time
Tijdsspanne: Baseline and 5 months

T1ρ relaxation time map of tibiofemoral cartilage from the lateral compartment of the knee joint assessed using 3T MRI

Baseline and 5 months
Lateral tibiofemoral T2 relaxation time
Tijdsspanne: Baseline and 5 months

T2 relaxation time map of tibiofemoral cartilage from the lateral compartment of the knee joint assessed using 3T MRI

Baseline and 5 months
Tibiofemoral loading during walking
Tijdsspanne: Baseline and 5 months

Tibiofemoral loading during walking assessed using musculoskeletal simulation

Baseline and 5 months
Knee Injury and Osteoarthritis Outcome Score (KOOS)
Tijdsspanne: Baseline and 5 months

The score range is from 0 to 100. 0 represents extreme problems / worst possible knee symptoms. 100 represents no problems / perfect knee health.

Baseline and 5 months

Andere uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
High-sensitivity C-reactive protein (hs-CRP)
Tijdsspanne: Baseline and 5 months

hs-CRP (mg/L) is measured from blood samples using a particle-enhanced immunoturbidimetric assay as a marker of systemic inflammation.

Baseline and 5 months
Glycated hemoglobin (HbA1c)
Tijdsspanne: Baseline and 5 months

HbA1c (mmol/mol) is measured from blood samples using turbidimetric inhibition immunoassay as a marker of long-term blood glucose control.

Baseline and 5 months
Knee cartilage recovery rate after loading assessed from magnetic resonance images
Tijdsspanne: Baseline and 5 months

The knee joint is loaded with 20 minutes of standing and followed by repeated magnetic resonance imaging. Cartilage is segmented from the images, and the temporal recovery of the cartilage thickness in the medial tibiofemoral joint is quantified. The unit is mm/min.

Baseline and 5 months
Proteomic analysis of serum samples
Tijdsspanne: Baseline and 5 months

Liquid chromatography-mass spectrometry is used to run non-targeted peptide analysis of serum proteins. This is a pre-planned exploratory analysis that identifies hundreds of proteins and their concentration in the sample.

Baseline and 5 months

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Onderzoekers

  • Hoofdonderzoeker: Lauri Stenroth, PhD, University of Eastern Finland

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Geschat)

15 november 2026

Primaire voltooiing (Geschat)

28 februari 2028

Studie voltooiing (Geschat)

31 maart 2028

Studieregistratiedata

Eerst ingediend

4 november 2026

Eerst ingediend dat voldeed aan de QC-criteria

15 november 2026

Eerst geplaatst (Werkelijk)

20 november 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

20 november 2026

Laatste update ingediend die voldeed aan QC-criteria

15 november 2026

Laatst geverifieerd

1 november 2026

Meer informatie

Termen gerelateerd aan deze studie

Andere studie-ID-nummers

  • 125/2025
  • 363854 (Ander subsidie-/financieringsnummer: Research Council of Finland)
  • FIMEA/2025/007528-5 (Andere identificatie: Finnish Medicines Agency)
  • 125/2025 (Andere identificatie: The Regional Medical Research Ethics Committee of Eastern Finland Collaborative Area)

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

JA

Beschrijving IPD-plan

IPD used in the publications is planned to be shared.

IPD-tijdsbestek voor delen

At the time of publication with no end date.

IPD-toegangscriteria voor delen

Open access to the IPD and supporting information to be used in scientific research. If possible, the data is made available at the time of publishing the results with link to the data repository at the publication.

IPD delen Ondersteunend informatietype

  • LEERPROTOCOOL
  • SAP
  • ICF

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren